Successful treatment of Pityriasis rubra pilaris with brodalumab

Australas J Dermatol. 2020 May;61(2):e249-e251. doi: 10.1111/ajd.13215. Epub 2019 Dec 18.

Authors

Alina De Rosa¹, Alessio Gambardella¹, Gaetano Licata¹, Roberto Alfano², Giuseppe Argenziano¹

Affiliations

¹ Dermatology Unit, Department of Mentals and Physical Health and Preventive medicine, University of Campania Luigi Vanvitelli Naples, Napoli, Italy.
² Department of Anesthesiology, Surgery and Emergency, University of Campania Luigi Vanvitelli, Naples, Italy.

PMID: 31851372
DOI: 10.1111/ajd.13215

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Dermatologic Agents / therapeutic use*
Humans
Male
Middle Aged
Pityriasis Rubra Pilaris / drug therapy*
Pityriasis Rubra Pilaris / pathology

Substances

Antibodies, Monoclonal, Humanized
Dermatologic Agents
brodalumab